We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.4B
2
NVDA icon
NVIDIA
NVDA
+$388M
3
MSFT icon
Microsoft
MSFT
+$182M
4
AMZN icon
Amazon
AMZN
+$177M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$163M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$213M
2
AVGO icon
Broadcom
AVGO
+$103M
3
UNP icon
Union Pacific
UNP
+$100M
4
ETHA
iShares Ethereum Trust ETF
ETHA
+$89.9M
5
MRVL icon
Marvell Technology
MRVL
+$89.4M

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSHRW
1876
Gesher Acquisition Corp II Warrants
GSHRW
$49.2K ﹤0.01%
120,000
-50,000
-29% -$21.2K
AXINR
1877
Axiom Intelligence Acquisition Corp 1 Right
AXINR
$48.9K ﹤0.01%
233,028
-166,972
-42% -$37.1K
RAC.WS
1878
Rithm Acquisition Corp Warrants
RAC.WS
$48K ﹤0.01%
80,000
-5,000
-6% -$3.3K
CHACR
1879
DELISTED
Crane Harbor Acquistion Corp Rights
CHACR
$48K ﹤0.01%
60,000
-140,000
-70% -$110K
MNOV icon
1880
MediciNova
MNOV
$66M
$47.2K ﹤0.01%
36,047
+1,397
+4% +$1.93K
ALT icon
1881
Altimmune
ALT
$591M
$47K ﹤0.01%
+13,021
New +$56.8K
ATIIW
1882
Archimedes Tech SPAC Partners II Co Warrant
ATIIW
$17.9M
$45.1K ﹤0.01%
82,192
-27,158
-25% -$13.4K
NWL icon
1883
Newell Brands
NWL
$2.54B
$44.7K ﹤0.01%
12,015
-143,192
-92% -$578K
OACCW
1884
Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
$3.72M
$44.3K ﹤0.01%
53,736
-5,184
-9% -$4.33K
NPACW
1885
New Providence Acquisition Corp III Warrants
NPACW
$2.1M
$43K ﹤0.01%
85,000
-32,568
-28% -$17K
STKL
1886
DELISTED
SunOpta
STKL
$42.4K ﹤0.01%
+11,159
New +$50.7K
NSPR icon
1887
InspireMD
NSPR
$34.6M
$41.5K ﹤0.01%
23,334
-62,758
-73% -$131K
SZZLR
1888
Sizzle Acquisition Corp II Right
SZZLR
$41.1K ﹤0.01%
257,022
-241,153
-48% -$50.8K
STXS icon
1889
Stereotaxis
STXS
$142M
$40.9K ﹤0.01%
17,801
+5,692
+47% +$15.2K
TACOW
1890
Berto Acquisition Corp Warrant
TACOW
$14.5M
$40.7K ﹤0.01%
110,000
+60,000
+120% +$30.5K
JENA.RT
1891
Jena Acquisition Corp II Rights
JENA.RT
$40K ﹤0.01%
235,000
+60,000
+34% +$13.5K
ACRV icon
1892
Acrivon Therapeutics
ACRV
$73.6M
$39.6K ﹤0.01%
+16,428
New +$35.7K
COPL.WS
1893
Copley Acquisition Corp Warrants
COPL.WS
$39.4K ﹤0.01%
174,699
-46,897
-21% -$12K
EQ icon
1894
Equillium
EQ
$133M
$39.3K ﹤0.01%
25,381
-99,442
-80% -$121K
PMTRW
1895
Perimeter Acquisition Corp I Warrant
PMTRW
$10.9M
$38.4K ﹤0.01%
54,303
-15,297
-22% -$12.8K
OCGN icon
1896
Ocugen
OCGN
$427M
$37.7K ﹤0.01%
+27,926
New +$39.8K
IVVD icon
1897
Invivyd
IVVD
$211M
$35.7K ﹤0.01%
+14,460
New +$30.1K
KOPN icon
1898
Kopin
KOPN
$789M
$34.9K ﹤0.01%
+14,901
New +$43K
DH icon
1899
Definitive Healthcare
DH
$74.1M
$34.6K ﹤0.01%
+12,058
New +$33.4K
HVMCW
1900
Highview Merger Corp Warrants
HVMCW
$34K ﹤0.01%
+125,813
New +$41.8K
74 75
76
77 78

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.